Trial
NCT02443194
The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
michal roll
Collaborators
—
Condition
Depression
Intervention
duloxetine
Why stopped
principle investigator decision due to many adverse events in patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-03